ArticlePDF Available

Difference Between Monoclonal and Polyclonal Antibodies

Authors:
  • The Biology Blog - WELCOME TO THE WORLD OF BIOLOGY

Abstract and Figures

Antibodies are a type of globular proteins produced by the plasma B cells in response to a specific antigen. An antigen can be a foreign molecule that interacts with the cells of the immune system, triggering an immune response. The molecules on the antigens to which the antibodies attach themselves are called epitopes. The region of the antibody which binds to the epitope is called a paratope. Monoclonal antibodies and polyclonal antibodies are the two varieties of antibodies, which are used in therapeutics as well as in research applications. Both monoclonal and polyclonal antibodies interact with the same antigen. The main difference between monoclonal and polyclonal antibodies is that monoclonal antibodies are produced by the same clone of plasma B cells, and they bind to a unique epitope whereas polyclonal antibodies are produced by different clones of plasma B cells, and they bind to the different epitopes in the same antigen.
Content may be subject to copyright.
10/30/2017 Difference Between Monoclonal and Polyclonal Antibodies | Definition, Production, Usage
http://pediaa.com/difference-between-monoclonal-and-polyclonal-antibodies/ 1/7
Home » Science » Biology » Immunology » Difference Between Monoclonal and Polyclonal Antibodies
Difference Between Monoclonal and Polyclonal
Antibodies
October 29, 2017 by Lakna 6 min read
Main Difference – Monoclonal vs Polyclonal Antibodies
Antibodies are a type of globular proteins produced by the plasma B cells in response to a specific antigen. An antigen
can be a foreign molecule that interacts with the cells of the immune system, triggering an immune response. The
molecules on the antigens to which the antibodies attach themselves are called epitopes. The region of the antibody
which binds to the epitope is called a paratope. Monoclonal antibodies and polyclonal antibodies are the two varieties
of antibodies, which are used in therapeutics as well as in research applications. Both monoclonal and polyclonal
antibodies interact with the same antigen. The main difference between monoclonal and polyclonal antibodies is that
monoclonal antibodies are produced by the same clone of plasma B cells, and they bind to a unique epitope
whereas polyclonal antibodies are produced by different clones of plasma B cells, and they bind to the different
epitopes in the same antigen.
Key Areas Covered
1. What are Monoclonal Antibodies
– Definition, Production, Usage
2. What are Polyclonal Antibodies
– Definition, Production, Usage
3. What are the Similarities Between Monoclonal and Polyclonal Antibodies
– Outline of Common Features
4. What is the Difference Between Monoclonal and Polyclonal Antibodies
– Comparison of Key Differences
Key Terms: Antigen, Epitope, Immunization, Monoclonal Antibodies, Paratopes, Plasma B Cells, Polyclonal
Antibodies
EXPLORE
Type here to search...
10/30/2017 Difference Between Monoclonal and Polyclonal Antibodies | Definition, Production, Usage
http://pediaa.com/difference-between-monoclonal-and-polyclonal-antibodies/ 2/7
What are Monoclonal Antibodies
10/30/2017 Difference Between Monoclonal and Polyclonal Antibodies | Definition, Production, Usage
http://pediaa.com/difference-between-monoclonal-and-polyclonal-antibodies/ 3/7
Monoclonal antibodies refer to a homogeneous population of antibodies which are produced by a single clone of
plasma B cells. This means the plasma B cell clone that produces a particular monoclonal antibody type is originated
from a common ancestral plasma B cell. The plasma B cells used for this purpose should only be harvested from a
specific location. First of all, the epitope, which is subjected for the production of monoclonal antibodies, should be
injected to a particular animal. This process is called immunization. Then, the animal may produce antibodies against
that epitope inside the body. Next, the immune cells should be harvested from a particular location. These plasma B
cells are fused with the myeloma cell to obtain an immortal population of hybridoma cells. The hybridoma cells are
cultured in HAT medium in order to obtain large populations of monoclonal plasma B hybridoma cells. Monoclonal
antibodies can be harvested from culture vessels, The process of the production of the monoclonal antibodies is shown
in figure 1.
Figure 1: Production of the Monoclonal Antibodies
Monoclonal antibodies can only recognize and bind to a specific epitope on the antigen. Therefore, these antibodies
can be used to identify the presence of a particular organism which causes disease to the host. Therefore, monoclonal
antibodies are mostly used as therapeutic agents.
What are Polyclonal Antibodies
10/30/2017 Difference Between Monoclonal and Polyclonal Antibodies | Definition, Production, Usage
http://pediaa.com/difference-between-monoclonal-and-polyclonal-antibodies/ 4/7
Polyclonal antibodies refer to a mixture of immunoglobulin molecules which are secreted against a particular antigen;
each antibody recognizes different epitopes. This means polyclonal antibodies are a heterogeneous mixture of
antibodies. Each type of antibodies in the mixture are originated from a specific clone of plasma B cells. Thereby, the
production of polyclonal antibodies employs multiple clones of plasma B cells. Immunization is the first step of the
production of polyclonal antibodies as well. An animal can be immunized by a particular antigen. This antigen may
contain several epitopes. The immune system produces different antibodies against each of the epitopes on the
injected antigen. Polyclonal antibodies can be harvested from the serum of the animal directly. The process of the
production of polyclonal antibodies is shown in figure 2.
Figure 2: Production of Polyclonal Antibodies
Polyclonal antibodies bind to multiple epitopes of the same antigen. This increases the capacity of detection of a
particular antigen.
Similarities Between Monoclonal and Polyclonal Antibodies
Both monoclonal and polyclonal antibodies are two varieties of antibodies.
Both monoclonal and polyclonal antibodies are produced by plasma B cells.
Both monoclonal and polyclonal antibodies interact with the same antigen.
Difference Between Monoclonal and Polyclonal Antibodies
Definition
Monoclonal Antibodies: Monoclonal antibodies refer to a homogeneous population of antibodies that are produced
by a single clone of plasma B cells.
Polyclonal Antibodies: Polyclonal antibodies refer to a mixture of immunoglobulin molecules that are secreted
against a particular antigen.
10/30/2017 Difference Between Monoclonal and Polyclonal Antibodies | Definition, Production, Usage
http://pediaa.com/difference-between-monoclonal-and-polyclonal-antibodies/ 5/7
Produced by
Monoclonal Antibodies: Monoclonal antibodies are produced by the same clone of plasma B cells.
Polyclonal Antibodies: Polyclonal antibodies are produced by different clones of plasma B cells.
Hybridoma Cell Lines
Monoclonal Antibodies: The production of monoclonal antibodies requires the production of hybridoma cell lines.
Polyclonal Antibodies: Polyclonal antibody production does not require hybridoma cells lines since the antibodies
can be harvested directly from the serum.
Antibody Population
Monoclonal Antibodies: Monoclonal antibodies are a homogeneous antibody population.
Polyclonal Antibodies: Polyclonal antibodies are a heterogeneous antibody population.
Interaction
Monoclonal Antibodies: Monoclonal antibodies interact with a particular epitope on the antigen.
Polyclonal Antibodies: Polyclonal antibodies interact with different epitopes on the same antigen.
Cost
Monoclonal Antibodies: Monoclonal antibodies are expensive to produce.
Polyclonal Antibodies: Polyclonal antibodies are inexpensive to produce.
Training
Monoclonal Antibodies: Skills are required to handle the technology for the production of monoclonal antibodies.
Polyclonal Antibodies: Fewer skills are required for the production of polyclonal antibodies.
Time taken for Production
Monoclonal Antibodies: The production of monoclonal antibodies require time.
Polyclonal Antibodies: Less time is taken for the production of polyclonal antibodies.
10/30/2017 Difference Between Monoclonal and Polyclonal Antibodies | Definition, Production, Usage
http://pediaa.com/difference-between-monoclonal-and-polyclonal-antibodies/ 6/7
About the Author: Lakna
Lakna, a graduate in Molecular Biology & Biochemistry, is a Molecular Biologist and has a
broad and keen interest in the discovery of nature related things
Cross Reactivity
Monoclonal Antibodies: Monoclonal antibodies possess less cross reactivity.
Polyclonal Antibodies: Polyclonal antibodies possess comparatively high cross reactivity.
Uses
Monoclonal Antibodies: Monoclonal antibodies are used as therapeutic drugs.
Polyclonal Antibodies: Polyclonal antibodies are used in general research applications.
Advantages
Monoclonal Antibodies: Immortal supply, high specificity, and high reproducibility are the advantages of the
monoclonal antibodies.
Polyclonal Antibodies: High affinity, tolerant of minor changes, and more robust detection are advantages of the
polyclonal antibodies.
Conclusion
Monoclonal and polyclonal antibodies are two types of antibodies that are used for different purposes. Monoclonal
antibodies are produced by the same clone of plasma B cells. Polyclonal antibodies are produced by different clones
of plasma B cells. Monoclonal antibodies interact with the same epitope in the antigen whereas polyclonal antibodies
interact with the different epitopes of the same antigen. The main difference between monoclonal and polyclonal
antibodies is the origin of the plasma B cells which produce antigens and the type of interactions of the antibodies.
Reference:
1. “MONOCLONAL ANTIBODIES.” Prospec, Available here.
2. “What is a polyclonal antibody?” How to make polyclonal antibodies, Available here.
Image Courtesy:
1. “Monoclonals” By Adenosine – Own work (CC BY-SA 3.0) via Commons Wikimedia
2. “Biochem-polyclonal production” By Mei.huang at English Wikibooks (CC BY 3.0) via Commons Wikimedia
10/30/2017 Difference Between Monoclonal and Polyclonal Antibodies | Definition, Production, Usage
http://pediaa.com/difference-between-monoclonal-and-polyclonal-antibodies/ 7/7
View all posts
You May Also Like These
Copyright © 2017 Pediaa.Com.
You May Like
Difference Between
Monoclonal and
Polyclonal...
Contact About Us
Comment
Name * Email * Website
Post Comment
Leave a Comment
... Each of the epitopes on the injected antigen is targeted by a unique antibody that the immune system makes. Directly from the animal's serum, polyclonal antibodies can be obtained 22 . Polyclonal antibodies have been explored for a variety of general research applications and diagnostic procedures as they exhibit high a nity for the target antigen and tolerance for slight changes in the target protein(https://www.creative-diagnostics.com/polyclonal-vs-monoclonal-antibodies.htm).Considering these applications, the polyclonal antibodies generated against recombinant dengue NS1 antigen from rabbits were evaluated in the present study. ...
Preprint
Full-text available
The vector-borne disease, dengue is caused by the dengue virus (DENV) and the illness spread by Aedes mosquitoes like Aedesaegypti and Aedesalbopictus. In the absence of antiviral drugs and vaccines, dengue prevention is centred on mosquito vector control. Current methods of dengue detection suffer from limitations. The non-structural protein-1 (NS1) antigen in secretory form is being employed as a diagnostic marker to identify dengue infection andAedes vector infections. This method involves the use of commercial dengue NS1 ELISA kits. In the present study, we have evaluated Rabbit Polyclonal Antibodies raised against the Dengue NS1 antigen (RPAD). The RPAD were tested against commercial recombinant dengue virus-2 NS1 antigen (rDNS1Ag) by standardized ELISA and Western Blotting. Further, the sensitivity of RPAD was checked against the NS1 antigens of different serotypes of DENV. The specificity of RPAD towards the NS1 antigens of other flavivirus was also tested.We found that the RPAD is specific and sensitive for detecting rDNS1Ag of all serotypes and it can be explored to detect DENV infection in the mosquito vectors collected from the field during the dengue outbreaks.
... Furthermore, the pioneering of recombinant mAbs, which are synthetic mAbs with identified sequences has brought new light to therapeutics [37]. As recombinant antibodies are specified at sequence level, they offer no batch-to-batch variation and can be produced in commercially available expression systems where mammalian cell lines are commonly used [38]. Live cells are another common mode of protein production [39]. ...
Article
Full-text available
Background Antibodies have proven to be remarkably successful for biomedical applications. They play important roles in epidemiology and medicine from diagnostics of diseases to therapeutics, treating diseases from incessant chronic diseases such as rheumatology to pandemic outbreaks. With no end in sight for the demand for antibody products, optimizations and new techniques must be expanded to accommodate this. Methods and Results This review discusses optimizations and techniques for antibody production through choice of discovery platforms, expression systems, cell culture mediums, and other strategies to increase expression yield. Each system has its own merits and demerits, and the strategy chosen is critical in addressing various biological aspects. Conclusions There is still insufficient evidence to validate the efficacy of some of these techniques, and further research is needed to consolidate these industrial production systems. There is no doubt that more strategies, systems, and pipelines will contribute to enhance biopharmaceutical production.
... For example, a rabbit polyclonal antibody with a dilution of 1:400 was used by Mo et al., 2016 while in our study, a rabbit monoclonal to PD-L1 was used at a dilution of 1:500. Therefore, it is justified that Mo et al., 2016 could find more PD-L1 positive cases than in the present study, since the polyclonal antibody has a higher sensitivity when detecting low-quantity proteins, while the monoclonal antibody is more susceptible to changes in antigen conformation due to processing or fixation [28]. ...
Article
Full-text available
Endometrial carcinoma is the only gynaecologic malignancy with a raising incidence and mortality, posing a major health concern worldwide. The upregulation of programmed death ligand 1 (PD-L1) on tumour cells causes T-cell suppression, which impedes antitumour immunity, promotes immune cell evasion and enhances tumour survival. The aim of this study was to evaluate PD-L1 expression in endometrial carcinoma and to correlate it with survival rate. A total of 59 cases of endometrial carcinoma were evaluated. Thirty-two cases of non-neoplastic endometrial tissue were included as control. PD-L1 immunohistochemistry was performed on all cases. PD-L1 expression was evaluated on tumour cells and immune cells. PD-L1 was positive in 62.7% (37/59) and 28.8% (17/59) of immune cells and tumour cells, respectively. PD-L1 expression in immune cells was significantly higher in endometrial carcinoma than in non-neoplastic endometrium (p < 0.001). Among the patients with endometrial carcinoma, PD-L1 expression in tumour cells was significantly higher in patients who died (10/15, 66.7%) compared to those who survived (7/44, 15.9%) (p < 0.001). It is noteworthy to point out that the expression of PD-L1 in tumour cells was significantly associated with a poor survival. This suggests that immunomodulation using PD-L1 inhibitors may be useful in advanced endometrial carcinoma.
... In IHC, polyclonal secondary antibody is more preferred than monoclonal secondary antibody because polyclonal antibody can effectively amplify the signal. Nevertheless, polyclonal antibody can generate non-specific signal [17] . Using QDs, we not only limited the non-specific signal but also obtained strong fluorescent signal which was not even seen by using polyclonal secondary antibody. ...
ResearchGate has not been able to resolve any references for this publication.